Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery

Plasma Concentrations ◽

Noncardiac Surgery ◽

Elevated Plasma ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia

Metabolism ◽

10.1016/j.metabol.2006.07.020 ◽

2006 ◽

Vol 55 (12) ◽

pp. 1599-1603 ◽

Cited By ~ 15

Author(s):

Thomas Lücke ◽

Dimitrios Tsikas ◽

Nele Kanzelmeyer ◽

Bernhard Vaske ◽

Anibh Martin Das

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Plasma Concentrations ◽

Elevated Plasma ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

1007-181 Oral folic acid does not reduce plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in hyperhomocysteinemic subjects

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)91874-8 ◽

2004 ◽

Vol 43 (5) ◽

pp. A445

Author(s):

Markus C Stuehlinger ◽

Bernhard Paulweber ◽

Jan Schirnhofer ◽

Otmar Pachinger ◽

Olaf Stanger

Keyword(s):

Nitric Oxide ◽

Folic Acid ◽

Nitric Oxide Synthase ◽

Plasma Concentrations ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis

American Journal of Hematology ◽

10.1002/ajh.21184 ◽

2008 ◽

Vol 83 (7) ◽

pp. 577-579 ◽

Cited By ~ 19

Author(s):

Precious P. Landburg ◽

Tom Teerlink ◽

Frits A.J. Muskiet ◽

Ashley J. Duits ◽

John‐John B. Schnog ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Sickle Cell ◽

Plasma Concentrations ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Oxide Synthase ◽

Painful Crisis

Cardiovascular effects of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) and evidence for ADMA metabolism in humans in vivo

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82419-1 ◽

2003 ◽

Vol 41 (6) ◽

pp. 303

Author(s):

Vinod Achan ◽

Michael Broadhead ◽

Mohammed Malaki ◽

James Leiper ◽

Raymond MacAllister ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Cardiovascular Effects ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure

Liver Transplantation ◽

10.1002/lt.21053 ◽

2007 ◽

Vol 13 (3) ◽

pp. 400-405 ◽

Cited By ~ 49

Author(s):

Rajeshwar P. Mookerjee ◽

R. Neil Dalton ◽

Nathan A. Davies ◽

Stephen J. Hodges ◽

Charles Turner ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Liver Failure ◽

Acute Liver Failure ◽

Important Determinant ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice

Journal of Neural Transmission ◽

10.1007/s00702-010-0443-2 ◽

2010 ◽

Vol 117 (9) ◽

pp. 1027-1032 ◽

Cited By ~ 11

Author(s):

Ozgur Gunduz ◽

Cetin Hakan Karadag ◽

Ahmet Ulugol

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Morphine Tolerance ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Suppression of Endothelial Progenitor Cells in Human Coronary Artery Disease by the Endogenous Nitric Oxide Synthase Inhibitor Asymmetric Dimethylarginine

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.04.066 ◽

2005 ◽

Vol 46 (9) ◽

pp. 1693-1701 ◽

Cited By ~ 171

Author(s):

Thomas Thum ◽

Dimitrios Tsikas ◽

Sylvia Stein ◽

Maximilian Schultheiss ◽

Martin Eigenthaler ◽

...

Keyword(s):

Nitric Oxide ◽

Coronary Artery Disease ◽

Human Coronary Artery ◽

Endogenous Nitric Oxide ◽

Artery Disease ◽

Synthase Inhibitor ◽

Human Coronary Artery Disease ◽

The endogenous nitric oxide synthase inhibitor Asymmetric Dimethylarginine (ADMA) predicts cardiac allograft vasculopathy progression

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-2007-967483 ◽

2007 ◽

Vol 55 (S 1) ◽

Author(s):

K Sydow ◽

L Potena ◽

W Fearon ◽

C Holweg ◽

H Luikart ◽

...

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Cardiac Allograft Vasculopathy ◽

Cardiac Allograft ◽

Allograft Vasculopathy ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes

Medical Hypotheses ◽

10.1016/j.mehy.2007.01.053 ◽

2007 ◽

Vol 69 (4) ◽

pp. 922-924 ◽

Cited By ~ 9

Author(s):

S. Yamagishi ◽

S. Ueda ◽

S. Okuda

Keyword(s):

Nitric Oxide ◽

Advanced Glycation End Products ◽

Advanced Glycation ◽

Glycation End Products ◽

End Products ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽

Plasma Concentrations of an Endogenous Nitric Oxide Synthase Inhibitor, NG,NG-Dimethylarginine

Annals of the New York Academy of Sciences ◽

10.1111/j.1749-6632.2001.tb05696.x ◽

2006 ◽

Vol 928 (1) ◽

pp. 378-378

Author(s):

Jun-Hyun Yoo ◽

Sung-Chang Lee

Keyword(s):

Nitric Oxide ◽

Nitric Oxide Synthase ◽

Plasma Concentrations ◽

Endogenous Nitric Oxide ◽

Synthase Inhibitor ◽